For research use only. Not for therapeutic Use.
Butyrylcarnitine is a metabolite in plasma, acts as a biomarker to improve the diagnosis and prognosis of heart failure, and is indicative of anomalous lipid and energy metabolism.
| Catalog Number | I014283 |
| CAS Number | 25576-40-3 |
| Synonyms | (3R)-3-butanoyloxy-4-(trimethylazaniumyl)butanoate |
| Molecular Formula | C11H21NO4 |
| Purity | ≥95% |
| InChI | InChI=1S/C11H21NO4/c1-5-6-11(15)16-9(7-10(13)14)8-12(2,3)4/h9H,5-8H2,1-4H3/t9-/m1/s1 |
| InChIKey | QWYFHHGCZUCMBN-SECBINFHSA-N |
| SMILES | CCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C |
| Reference | [1]. Cheng ML, et al. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. J Am Coll Cardiol. 2015 Apr 21;65(15):1509-20. |
